BiologicalActivity
PotentPDGFRfamilyinhibitor(IC50valuesare1.2,2,7.7and10.5nMforKIT,FLT3,PDGFRβandCSF1Rrespectively;Kd=1.3nMforPDGFRα).Exhibits>30-foldselectivityoverapanelofotherkinasesandexhibitsnoactivityagainstcytochromeP450.Causestumorregressionofleukemiacellxenograftsinmice.Alsoreducesjointswellingandinflammationinamousemodelofcollagen-inducedarthritis.Orallyactive.
CompoundLibraries
AC710isalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxII.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
TechnicalData
M.Wt | 562.7 |
Formula | C31H42N6O4 |
Storage | Storeat+4°C |
Purity | ≥99%(HPLC) |
CASNumber | 1351522-04-7 |
PubChemID | 54760053 |
InChIKey | JVCWPUFNLFSKFS-UHFFFAOYSA-N |
Smiles | CC(C2)(C)N(CC)C(C)(C)CC2OC1=CC=C(C(NC3=CC=C(NC(NC4=NOC(C(C)(C)C)=C4)=O)C=C3)=O)N=C1 |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 11.25 | 20 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight562.7.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 1.78mL | 8.89mL | 17.77mL |
5mM | 0.36mL | 1.78mL | 3.55mL |
10mM | 0.18mL | 0.89mL | 1.78mL |
50mM | 0.04mL | 0.18mL | 0.36mL |